Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Seres Therapeutics (MCRB) Revenue: 2016-2023

Historic Revenue for Seres Therapeutics (MCRB) over the last 8 years, with Dec 2023 value amounting to $126.3 million.

  • Seres Therapeutics' Revenue was N/A to $351,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $107,000, marking a year-over-year change of. This contributed to the annual value of $126.3 million for FY2023, which is 1672.24% up from last year.
  • According to the latest figures from FY2023, Seres Therapeutics' Revenue is $126.3 million, which was up 1,672.24% from $7.1 million recorded in FY2022.
  • Over the past 5 years, Seres Therapeutics' Revenue peaked at $144.9 million during FY2021, and registered a low of $7.1 million during FY2022.
  • Over the past 3 years, Seres Therapeutics' median Revenue value was $126.3 million (recorded in 2023), while the average stood at $92.8 million.
  • Per our database at Business Quant, Seres Therapeutics' Revenue plummeted by 95.08% in 2022 and then surged by 1,672.24% in 2023.
  • Yearly analysis of 5 years shows Seres Therapeutics' Revenue stood at $34.5 million in 2019, then dropped by 3.74% to $33.2 million in 2020, then spiked by 336.33% to $144.9 million in 2021, then crashed by 95.08% to $7.1 million in 2022, then spiked by 1,672.24% to $126.3 million in 2023.